Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-03

Study Completion Date

2028-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study does not modify patient management or treatment. All patients undergoing treatment with an arterial allograft preserved at +2/+8°C as part of an arterial revascularization in a septic environment in either of the two centers between January 2024 and January 2025 will be included.

Imaging exams and clinical follow-up data will be analyzed. Reinterventions and causes of death will be recorded. All imaging required for the 6-month follow-up is routinely performed as part of standard care. No modification of patient management is planned.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Thoracal Abdominal Aneurysms

NCT01354821

Aortic Aneurysm

UNKNOWN NA

Outcomes of Surgically Ineligible Patients With Multivessel CAD

NCT02996877

Coronary Artery Disease

COMPLETED

Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.

NCT06059053

Aortic Aneurysm Endovascular Aortic Repair Stent-Graft Endoleak

RECRUITING

Hemodynamic Changes in the Aorta After Endovascular Treatment of the Aortic Dissection

NCT03669055

Aortic Dissection

COMPLETED NA

Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells

NCT02919709

Thoracic or Abdominal Aortic Aneurysm With no Indication for Surgical Treatment

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Revascularization in a Septic or Potentially Septic Environment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The study group will include all patients requiring bypass revascularization in a septic or high-ris

The study group will include all patients requiring bypass revascularization in a septic or high-risk septic environment, for whom a biomaterial is preferred over a prosthetic graft due to the unavailability of the patient's autologous saphenous vein

arterial revascularization

Intervention Type PROCEDURE

arterial revascularization

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

arterial revascularization

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient
* Requiring revascularization in a septic or high-risk septic environment
* With an estimated life expectancy of 12 months or more based on medical and surgical assessment
* Informed about the study